Milliarden-Deal! Ausgerechnet Vertex schlägt zu
Große Pharma- und Biotech-Unternehmen sind weiter auf der Suche nach aussichtsreichen Substanzen, um ihre Produktpipeline zu stärken. Der unangefochtene Weltmarktführer…
430,175€
-1,20%
Echtzeit-Aktienkurs Vertex Pharmaceuticals
Bid:
Ask:
Nachrichten zur Vertex Pharmaceuticals Aktie
Milliarden-Deal! Ausgerechnet Vertex schlägt zu
Große Pharma- und Biotech-Unternehmen sind weiter auf der Suche nach aussichtsreichen Substanzen, um ihre Produktpipeline zu stärken. Der unangefochtene Weltmarktführer…
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion
…
Übernahme: Vertex Pharmaceuticals erwirbt Alpine Immune für Milliardensumme
Das biopharmazeutische Unternehmen will die Biotechfirma für rund 4,9 Milliarden Dollar übernehmen. Die Aktien von Alpine legten nachbörslich 36 Prozent…
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion
With the acquisition, Vertex will add Alpines portfolio of protein-based immunotherapies to treat autoimmune and inflammatory diseases.…
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion By Reuters
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion…
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 bln
Vertex Pharmaceuticals will acquire therapy developer Alpine Immune Sciences for $65 per share, or about $4.9 billion in cash, the…
Biotech Stocks: 5 Biggest Companies in 2024
What are the top biotech companies? The following five stocks have market capitalizations worth billions of dollars and operate in…
Vertex Pharmaceuticals: Ein führender Schmerzmediziner "bemerkenswert negativ" zu VX-548 - Aktienanalyse
Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets:
Die Analysten vom Investmenthaus RBC Capital Markets trauen der Aktie von Vertex…
Vertex Pharmaceuticals executive sells shares worth over $100k By Investing.com
Vertex Pharmaceuticals executive sells shares worth over $100k…
Vertex (VRTX) Continues to Diversify Beyond CF Franchise
While CF remains the main area of focus for Vertex Pharmaceuticals (VRTX), it is seeing success in the development of…
Vertex (VRTX) Kidney Disease Drug to Enter Clinical Development
Vertex Pharmaceuticals (VRTX) plans to begin a phase I study on VX-407 in autosomal dominant polycystic kidney disease later this…
Vertex Pharmaceuticals: Diversifying Its Drug Portfolio For Future Growth
…
Forget Tesla, Buy This Magnificent Healthcare Stock Instead
Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future.…
5 Small Biotech ETFs to Watch (Updated 2024)
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…
3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow
Vertex shares have climbed almost 50% over the past year.…
3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow @themotleyfool #stocks $VRTX $CRSP
Vertex shares have climbed almost 50% over the past year.…
The Zacks Analyst Blog Highlights JPMorgan Chase, Salesforce, Vertex Pharmaceuticals, Palo Alto Networks and The Williams Companies
JPMorgan Chase, Salesforce, Vertex Pharmaceuticals, Palo Alto Networks and The Williams Companies are part of the Zacks top Analyst Blog.…